During AD pathology, APBA1 protein modulates the secretory and endocytic trafficking of APP whereas APBA2 accelerates APP endocytosis which leads to autophagosomes that enhances amyloid-β internalization60,61. Here, APBA2 is linked to Alzheimer disease.